Microsoft's (NASDAQ:MSFT) upcoming earnings report could be mixed due to new metrics published in August that are not yet ...

We recently compiled a list of the 20 Trending AI Stocks on Latest News and Ratings. In this article, we are going to take a ...

Investors often prefer to invest in shares held by company insiders, as management is typically more aligned with the company’s success and shareholder interests. Currently, insiders own just 8.04% of ...

On Friday, Akebia Therapeutics Inc (AKBA) stock saw a modest uptick, ending the day at $1.34 which represents a slight increase of $0.01 or 0.75% from the prior close of $1.33. The stock opened at $1.

In a reminder that stretched valuations make for poor timing signals, Piper Sandler strategist Michael Kantrowitz observed in ...

Piper Sandler analyst Allison Bratzel maintained a Hold rating on Humacyte (HUMA – Research Report) today and set a price target of ...

In a report released today, Kashy Harrison from Piper Sandler maintained a Hold rating on SolarEdge Technologies (SEDG – Research ...

Jimmy Dunne, the Wall Street deal maker who helped architect the PGA Tour’s controversial deal with the Saudi Arabian Public ...

Piper Sandler Companies' investments in its restructuring franchise, starting some years ago, are paying off as it carries ...

Piper Sandler believes Microsoft (NASDAQ: MSFT)'s upcoming earnings report on October 30 could be "mixed," citing challenges ...

"Stocks can remain at rich valuations as long as a 'fear' catalyst doesn't arise from" interest rates, employment, or ...

We recently made a list of Piper Sandler’s Top Technical Stock Picks: 20 Best Stocks. In this piece, we will look at where ...